Astec Lifesciences Limited manufactures crop-protection chemicals, agrochemical intermediates, and related products for agricultural applications. Its portfolio includes fungicides, herbicides, insecticides, and chemical intermediates supplied to domestic and international markets. The company benefits from demand for crop-protection solutions and India's position as a manufacturing base for agrochemicals. Product development and expansion into specialized molecules can support future growth. Agrochemical prices, raw-material costs, regulatory approvals, export demand, inventory cycles, and competition remain important factors.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROE previous year | ROCE | Debt / equity | Free cash flow | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1,551 cr | ₹441 cr | ₹-67 cr | — | -30.27 | 3.97 | -25.9% | -44.6% | -5.7% | 1.15 | ₹-86 cr | 0.82 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 84 | -19 | -8.40 | — | -8.2% | -22.4% |
| Mar 2026 | 159 | -8 | -3.48 | — | -25.7% | -4.9% |
| Dec 2025 | 125 | -16 | -7.04 | — | +32.9% | -12.6% |
| Sep 2025 | 74 | -24 | -11.35 | — | -25.2% | -33.1% |
| Jun 2025 | 91 | -33 | -16.85 | — | +31.3% | -36.3% |
| Mar 2025 | 213 | -56 | -28.79 | — | +38.8% | -26.5% |
| Dec 2024 | 94 | -40 | -20.59 | — | +84.8% | -43.0% |
| Sep 2024 | 98 | -38 | -19.66 | — | -11.1% | -39.1% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | — Not assessable |
| EPS growth accelerating over 3 quarters | — Not assessable |
| Sales up 25%+, or sales growth accelerating | ✗ Fail |
| Annual EPS up 25%+ in each of the last 2 years | — Not assessable |
| Net margin above the same quarter last year | ✓ Pass |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✓ Close above the 50-day ✓ At least 25% above the 52-week low · low 521.85 ✓ Within 25% of the 52-week high · high 918.75 ✗ RS percentile 70 or more · RS 53 Trend template - the gate, measured: a modest 21-day edge. | 5/8 | 5 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 2 - advancing | |
| CAN SLIM | — C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 918.75 ✓ S more volume on up days than down days (50 sessions) · 5.94x ✗ L RS percentile 80 or more · RS 53 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 2/4 | Average |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 825.95 ✗ Close above the prior 20-session high · 825.95 ✗ Close below the prior 20-session low · 684.80 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Graham | Needs positive earnings and book value. | Not assessable | |
| Piotroski | ✗ Profitable (ROA > 0) ✗ Operating cash flow positive ✓ ROA rising ✓ Cash flow above net profit (earnings quality) ✓ Long-term debt / assets falling ✗ Current ratio rising · 0.89 ✗ No new shares issued ✓ Margin rising (net margin) ✗ Asset turnover rising Joseph Piotroski's F-score, FY 2025 -> 2026. | 4/9 | Weak |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTEC this stock | -4.2 | +1.5 | -1.4 | -4.5 | -46.3 | -45.0 | — | 3.97 | -25.9 | -5.7 | — | 1.15 | — | 1,551 | 441 | -67 | -30.3 | 0.82 |
| BODALCHEM | -14.3 | +149.1 | +142.6 | +175.9 | +104.7 | +20.3 | 30.1 | 1.78 | 4.2 | 6.7 | — | 0.69 | 14.2 | 2,065 | 2,267 | 69 | 5.5 | 0.70 |
| RPEL | +7.6 | +38.6 | +149.7 | +161.5 | — | — | 115.8 | 28.99 | 25.0 | 31.2 | — | 0.02 | 85.7 | 8,164 | 315 | 70 | 15.3 | 1.42 |
| FCL | -2.1 | +41.7 | +142.9 | +128.2 | +70.0 | +356.5 | 43.9 | 7.36 | 13.5 | 18.3 | — | 0.01 | 39.5 | 6,499 | 1,012 | 148 | 1.3 | 1.46 |
| AETHER | -6.7 | +4.9 | +28.3 | +104.1 | +70.3 | — | 85.6 | 8.22 | 9.4 | 11.6 | — | 0.18 | 55.5 | 20,191 | 1,224 | 235 | 17.8 | 0.75 |
| KRISHANA | +18.3 | +46.5 | +66.7 | +87.6 | +322.8 | +1076.5 | 33.5 | 11.74 | 38.1 | 27.3 | — | 1.31 | 22.8 | 6,581 | 2,555 | 197 | 6.4 | 1.04 |
| OAL | +21.4 | +78.0 | +98.3 | +85.2 | +69.9 | -28.9 | 395.2 | 3.16 | 0.5 | 4.5 | — | 0.61 | 32.3 | 2,101 | 1,065 | 5 | 1.6 | 0.97 |
| NEOGEN | -0.3 | +13.7 | +66.1 | +70.0 | +43.2 | +81.2 | 186.7 | 8.32 | 3.6 | 6.6 | — | 1.63 | 56.6 | 6,795 | 926 | 36 | 13.3 | 0.84 |
| NAVINFLUOR | -5.1 | +3.7 | +26.0 | +59.6 | +123.5 | +111.1 | 52.9 | 10.52 | 20.1 | 21.4 | — | 0.31 | 37.8 | 41,822 | 3,634 | 790 | 154.2 | 0.78 |
| VALIANTORG | +9.1 | +74.3 | +72.0 | +59.4 | -0.5 | -70.1 | 24.0 | 1.72 | 4.5 | 6.2 | — | 0.33 | 15.5 | 1,305 | 766 | 54 | 19.4 | 1.02 |
| ICIL | -5.3 | +8.0 | +58.0 | +58.8 | +74.0 | +46.7 | 55.6 | 3.56 | 5.5 | 8.7 | — | 0.46 | 21.0 | 8,394 | 4,390 | 151 | 7.6 | 1.50 |